Informatie:
Fout:
ID
13592
Beschrijving
Study of XL999 in Patients With Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00322673
Link
https://clinicaltrials.gov/show/NCT00322673
Trefwoorden
Versies (1)
- 18-02-16 18-02-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
18 februari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT00322673
Eligibility Acute Myeloid Leukemia NCT00322673
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT00322673
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
AML
Item
diagnosis of acute myeloid leukemia (except aml fab-m3 or acute promyelocytic leukemia [apl]) based on the world health organization (who) classification of ≥ 20% blasts in the bone marrow or peripheral blood at initial diagnosis (prior to start of standard chemotherapy)
boolean
C0023467 (UMLS CUI [1])
C1982687 (UMLS CUI [2])
C0368761 (UMLS CUI [3])
C1982687 (UMLS CUI [2])
C0368761 (UMLS CUI [3])
ecog
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
Item
subjects with newly-diagnosed aml or subjects with relapsed aml after at least 2 chemotherapy regimens.
boolean
C0023467 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
C1518321 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0277556 (UMLS CUI [2,2])
liver and renal function
Item
adequate liver and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
anticancer therapy
Item
anticancer therapy including chemotherapeutic, biologic, or investigative agents within 30 days of xl999 treatment
boolean
C0920425 (UMLS CUI [1])
stem cell transplantation
Item
hematopoietic stem cell transplantation within the previous 6 weeks
boolean
C1504389 (UMLS CUI [1])
immunosuppressive therapy
Item
immunosuppressive therapy (eg, cyclosporine, steroids, tacrolimus) for graft-versus-host disease (gvhd) within 30 days prior to the start of xl999
boolean
C0021079 (UMLS CUI [1])
C0018133 (UMLS CUI [2])
C0018133 (UMLS CUI [2])
adverse events recovery
Item
the subject has not recovered to grade ≤ 1 or to within 10% of baseline from adverse events due to investigational or chemotherapeutic drugs or stem cell transplantation which were administered > 4 weeks prior to study enrollment
boolean
C0877248 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,2])
uncontrolled and/or concomitant illness
Item
uncontrolled and/or concomitant illness
boolean
C0009488 (UMLS CUI [1])
pregnant or breastfeeding females
Item
pregnant or breastfeeding females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
hiv
Item
known hiv
boolean
C0019682 (UMLS CUI [1])